[Percutaneous therapies for aortic and mitral valvular disease]. / Traitement percutané des atteintes valvulaires aortiques et mitrates.
Rev Med Suisse
; 3(113): 1360-1, 1363-4, 1366-7, 2007 May 30.
Article
en Fr
| MEDLINE
| ID: mdl-17645049
For a few years, numerous articles and lectures were published as well as presented at major meetings on percutaneous therapies for valvular heart disease. Calcific aortic stenosis in the elderly is frequent and difficult to manage with 1/3 of patients not operated because of high surgical risks. In 2002, the first percutaneous aortic valve bioprosthesis was implanted. Since then, several hundreds of interventions were performed with 2 different valves (Cribier-Edwards, Corevalve). Preliminary results are encouraging. Regarding percutaneous mitral valve interventions, balloon valvuloplasty for stenosis is well established but treatment modalities for mitral insufficiency remain complex due to a wide disease spectrum. Therefore, development is more at a preliminary level and the window of application may be narrower, but still attractive.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Estenosis de la Válvula Aórtica
/
Estenosis de la Válvula Mitral
Límite:
Humans
Idioma:
Fr
Revista:
Rev Med Suisse
Asunto de la revista:
MEDICINA
Año:
2007
Tipo del documento:
Article
Pais de publicación:
Suiza